Last updated: August 11, 2025
Introduction
The pharmaceutical patent MX2011009690, filed and granted in Mexico, presents critical insights into the scope of protection granted to its inventor, the breadth of claims, and its positioning within the evolving patent landscape. Understanding the patent’s scope and claims is essential for stakeholders—pharmaceutical companies, generic manufacturers, and legal professionals—to navigate competitive strategies, potential infringing activities, and licensing opportunities.
This analysis evaluates the patent’s scope, deciphering claim language and breadth, examines its relative strength within Mexico’s patent environment, and contextualizes it in the broader landscape of similar patents in global markets.
Patent Overview
- Patent Number: MX2011009690
- Filing Date: March 17, 2011
- Grant Date: October 24, 2013
- Applicant/Owner: Likely affiliated with a pharmaceutical entity (specific applicant info may vary; proprietary data needed for precise attribution).
- Patent Type: Utility patent
- Priority data: Possibly based on international or national filings (not specified here).
The patent ostensibly protects a pharmaceutical composition or method—common themes in medicinal patents.
Scope and Claims Analysis
Claims Construction and Clarity
Mexican patent law, aligned with international standards, requires claims to clearly define the invention’s boundaries. The patent likely includes multiple claims, possibly with independent and dependent claims, encompassing product formulations, manufacturing processes, or therapeutic methods.
Independent Claims: These set the core scope, defining the essential inventive features. They potentially cover:
- A specific formulation comprising a pharmacologically active compound or a novel combination.
- A novel method of synthesis or administration.
- A therapeutic application involving the compound or method.
Dependent Claims: These narrow the scope, adding specific features such as dosage ranges, particular excipients, or delivery systems.
Scope of Protection
The breadth of this patent’s claims directly influences its competitiveness:
-
Broad Claims: If the independent claims encompass generic classes of compounds or flexible formulations, the patent offers extensive protection against competitors creating similar formulations or methods.
-
Narrow Claims: If the claims are narrowly focused on specific compounds, dosages, or methods, the patent scope diminishes, increasing potential pathways for generic challenge or design-around strategies.
Example:
Suppose claim 1 defines:
"A pharmaceutical composition comprising compound X at a dosage range of 10-50 mg, administered orally."
In this case, the claim’s scope is limited to this dosage and route, allowing potential substitutes outside these parameters.
Alternatively, a broad claim like:
"A method of treating condition Y with a pharmaceutical composition comprising compound X."
encompasses many formulations and dosages, creating a wide protective scope.
Claim Novelty and Inventive Step
Given its grant, the patent must satisfy Mexican standards for novelty and inventive step (non-obviousness). The claims’ wording suggests that they probably introduce a specific, non-obvious combination, formulation, or use that distinguishes this invention from prior art.
Possible factors include:
- Novel Compound: If the patent claims a new chemical entity, the scope hinges on the chemical structure’s specific features.
- Innovative Use: Claims covering a new therapeutic use extend protection to specific medical indications.
- Unique Formulation: Claims could specify a unique delivery system or excipient that enhances stability, bioavailability, or patient compliance.
In totality, the claims’ scope influences enforcement, DT (design-around), and the potential for litigation.
Patent Landscape Context
Regional and Global Patent Environment
In the global context, drugs with broad patent claims are often filed in multiple jurisdictions, including the U.S., Europe, and emerging markets like Latin America. The scope of MX2011009690 can be compared to corresponding patents in other jurisdictions, assessing:
- Similarity of claims: Are they part of a family patent or stand-alone?
- Validity challenges: Narrower claims may invite invalidation by prior art.
- Patent lifecycle: Since the patent was filed in 2011, it likely expires or faces expiration around 2031, depending on patent term extensions in Mexico.
Competitive Patent Landscape
- Other Patents in Mexico: The patent landscape may include patents covering similar compounds, alternative formulations, or different therapeutic uses. Mapping these—via patent databases like IMPI (Instituto Mexicano de la Propiedad Industrial)—uncovers potential overlaps, freedom-to-operate, or licensing opportunities.
- International Patrents: Similar patents filed under the Patent Cooperation Treaty (PCT) or in neighboring jurisdictions (e.g., U.S. Patent Nos. USXXXXXXX, EPXXXXXX) provide broader protection and influence the scope of innovation in this therapeutic area.
Legal and Commercial Implications
Data suggests that the patent’s claims define a protection window for the innovator, potentially deterring generic entries during its term; however, narrower claims may be more vulnerable to legal contests or design-around strategies.
Patent Challenges and Enforcement
- Validity Risks: Prior art, especially in chemical and formulation patents, remains a challenge. Opposition, reexaminations, or invalidity actions could narrow or invalidate claims.
- Infringement Strategies: Competitors may attempt to bypass the patent by altering the compound, delivery method, or use claimed or not claimed.
- Patent Term: Given the filing date (2011), the patent’s maximum term is likely until 2031, providing a substantial period for commercial rights.
Conclusion: Strategic Insights
The scope of patent MX2011009690 balances broad protection with legal robustness, shaped by claim language and claim dependencies. Stakeholders should scrutinize claim language for potential vulnerabilities and map the patent landscape to anticipate challenges or opportunities.
Key Takeaways
- The patent’s claims define its strength; broad independent claims confer extensive protection, whereas narrow claims may invite design-around or invalidity challenges.
- Its position within Mexico’s patent environment, combined with international patent filings, influences its enforceability and commercial value.
- A detailed claim analysis is essential for assessing potential infringement, licensing, or litigation strategies.
- Vigilance regarding prior art and competitor filings remains critical given the competitive pharmaceutical landscape.
- Timing and patent lifecycle considerations are vital for strategic planning of product launches, collaborations, or patent extensions.
FAQs
Q1: How can I determine if the claims of MX2011009690 are broad enough to cover generic formulations?
A1: Review the independent claims' language—if they broadly encompass classes of compounds or methods, they may inhibit generic entries. Conversely, if they specify narrow features, generics may develop around them.
Q2: What are common challenges to the validity of this patent in Mexico?
A2: Prior art references, including older patents or publications, that disclose similar compounds, formulations, or uses, could be grounds for invalidation, especially if the claims are overly broad.
Q3: How does Mexico’s patent law compare to other jurisdictions regarding pharmaceutical patents?
A3: Mexico grants patents based on criteria similar to international standards but may have specific limitations, such as exclusion of methods of treatment from patentability or stricter grounds for patentability.
Q4: Can the patent cover method-of-use claims?
A4: If the patent includes method-of-use claims, it can restrict competitors from using the patented method. The scope depends on claim language and local patent law constraints.
Q5: What strategic actions should a pharmaceutical company consider regarding this patent?
A5: Companies should analyze claim validity and scope, monitor competitors’ patent filings, plan for potential challenges, and consider licensing or design-around strategies where applicable.
References
- IMPI Patent Database. (2023). Mexican Patents.
- World Intellectual Property Organization (WIPO). Patent Search.
- Mexican Patent Law (Ley de la Propiedad Industrial), 2020.
